GSWM
ORMP icon

Golden State Wealth Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Golden State Wealth Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Hold
303
– – ﹤0.01% 1438
2026
Q1 		$1.03K Hold
303
– – ﹤0.01% 1446
2025
Q4 		$864 Hold
303
– – ﹤0.01% 1534
2025
Q3 		$800 Hold
303
– – ﹤0.01% 1527
2025
Q2 		$682 Hold
303
– – ﹤0.01% 1471
2025
Q1 		$648 Hold
303
– – ﹤0.01% 1477
2024
Q4 		$733 Buy
+303
New +$720 ﹤0.01% 1393

Other funds holding ORMP

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
SCM
Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFO
Pioneer Family Office North Miami Beach, Florida $194M AUM

Golden State Wealth Management's ORMP Position: Q2 2026 in Review

Golden State Wealth Management held its Oramed Pharmaceuticals (ORMP) position steady in Q2 2026 at 303 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

Golden State Wealth Management first reported a position in ORMP in Q4 2024 and has held it in 7 quarters since. 14 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Golden State Wealth Management held 303 shares of Oramed Pharmaceuticals worth $1.46K as of Q2 2026.
  • Golden State Wealth Management left its Oramed Pharmaceuticals share count unchanged in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1438 holding.
  • Golden State Wealth Management first reported a position in Oramed Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 14 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.